May 4, 2021 Updated: May 4, 2021 4:52 p.m.
ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) reported a loss of $ 90.9 million in the first quarter on Tuesday.
The Ann Arbor, Michigan based company said it posted a loss of $ 3.50 per share.
The results did not meet Wall Street expectations. The average estimate by six analysts surveyed by Zacks Investment Research was a loss of $ 2.08 per share.
The biopharmaceutical company had sales of $ 8 million for the period, which also fell short of Street’s forecasts. Four analysts surveyed by Zacks expected $ 20.4 million.
Esperion Therapeutics’ shares are down nearly 2% since the start of the year. In the last few minutes of trading Tuesday, shares hit $ 25.59, down 35% over the past 12 months.
_____
This story was created by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR
Comments are closed.